A strategy to mitigate toxicities associated with AAV doses of 1E14 vg/kg or higher by enabling repeated vector administrations at 5E13 vg/kg P. O. Ilyinskii, C. J. Roy, A. M. Michaud, G. L. Rizzo, T. Capela,S. S. Leung,T. K. KishimotoHUMAN GENE THERAPY（2022）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
